Topic
Marketing Authorisation
30 published works
BioSlice Blog
European Commission Publishes New Variation Guidelines for Medicines
By Alexander Roussanov, Ana Gonzalez-Lamuno
The European Commission has published new Guidelines on the details of the various categories of variations (to the terms of marketing authorisations (“MA”) for medicinal products) (“Variations Guidelines”). The new…
The Continuum of Risk
FDA Issues First Marketing Authorization for Oral Nicotine Pouches
By Azim Chowdhury, Neelam Gill
In a groundbreaking move, FDA has kicked off the year with its very first marketing authorization for an oral nicotine pouch product. On January 16, 2025, FDA authorized twenty ZYN…
Regulatory Oversight
Vape Companies Challenge Iowa’s New Vape Directory Law
By Agustin Rodriguez, Nick Ramos
On December 17, 2024, Iowans for Alternatives to Smoking & Tobacco, Inc., Global Source Distribution, LLC, and others filed a complaint[1] and motion for a preliminary injunction[2] in federal district…
Big Molecule Watch
EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab)
By Tara Thigpen
On November 4, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech’s biosimilar to Simponi® (golimumab), for the…
Big Molecule Watch
Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma)
By Lihui Bai
On July 08, 2024, Outlook Therapeutics announced it received marketing authorization from UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of wet AMD in the UK. As…
Global Regulation Tomorrow
FCA updates webpage on landing slots for funds in temporary marketing permissions regime
By Simon Lovegrove (UK), Anita Edwards
On 9 October 2023, the FCA updated its webpage on landing slots for funds in the temporary marketing permissions regime (TMPR). The webpage explains that the process of exiting the…
Global Regulation Tomorrow
FCA publishes new webpage: Landing slots for funds in temporary marketing permissions regime
By Simon Lovegrove (UK), Anita Edwards
On 19 September 2023, the FCA published a new webpage on landing slots for funds in the temporary marketing permissions regime (TMPR). The webpage explains that, in the coming months,…
Global Policy Watch
EU Pharma Legislation Review Series: Temporary Emergency Marketing Authorizations
Following the COVID-19 pandemic and the relatively slow approval of vaccines in the EU versus other key jurisdictions, as part of the EU’s General Pharmaceutical Legislation amendment proposal, published on 26 April 2023,…
Inside EU Life Sciences
EU Pharma Legislation Review Series: Temporary Emergency Marketing Authorizations
Following the COVID-19 pandemic and the relatively slow approval of vaccines in the EU versus other key jurisdictions, as part of the EU’s General Pharmaceutical Legislation amendment proposal, published on 26…
Inside EU Life Sciences
EU Pharma Legislation Review Series: Marketing Authorisations
By Marie Doyle-Rossi, Grant Castle
The European Commission’s proposal to amend the EU's general pharmaceutical legislation includes a new draft directive replacing Directive 2001/83/EC (the draft Directive) and a new draft regulation replacing Regulation (EC)…